1. Home
  2. PHAR vs ORC Comparison

PHAR vs ORC Comparison

Compare PHAR & ORC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$16.62

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Orchid Island Capital Inc.

ORC

Orchid Island Capital Inc.

HOLD

Current Price

$7.38

Market Cap

1.2B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
PHAR
ORC
Founded
1988
2010
Country
Netherlands
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
PHAR
ORC
Price
$16.62
$7.38
Analyst Decision
Strong Buy
Hold
Analyst Count
2
3
Target Price
$38.00
$7.50
AVG Volume (30 Days)
22.5K
6.4M
Earning Date
11-06-2025
01-29-2026
Dividend Yield
N/A
19.62%
EPS Growth
N/A
N/A
EPS
0.00
0.57
Revenue
$362,274,000.00
$80,187,000.00
Revenue This Year
$24.80
$82.99
Revenue Next Year
$6.84
$61.79
P/E Ratio
$2,946.57
$12.79
Revenue Growth
26.78
5.93
52 Week Low
$7.50
$5.69
52 Week High
$18.12
$9.01

Technical Indicators

Market Signals
Indicator
PHAR
ORC
Relative Strength Index (RSI) 51.06 58.78
Support Level $16.23 $7.09
Resistance Level $17.00 $7.44
Average True Range (ATR) 0.75 0.12
MACD -0.16 0.02
Stochastic Oscillator 36.44 67.19

Price Performance

Historical Comparison
PHAR
ORC

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

About ORC Orchid Island Capital Inc.

Orchid Island Capital Inc is a specialty finance company that invests in residential mortgage-backed securities. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.

Share on Social Networks: